Vida Ventures

Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease

Develops ultrasound-mediated nonviral genetic medicines

Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions

Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions